ES8705883A1 - Procedimiento para preparar nuevas piridazinonas - Google Patents
Procedimiento para preparar nuevas piridazinonasInfo
- Publication number
- ES8705883A1 ES8705883A1 ES557218A ES557218A ES8705883A1 ES 8705883 A1 ES8705883 A1 ES 8705883A1 ES 557218 A ES557218 A ES 557218A ES 557218 A ES557218 A ES 557218A ES 8705883 A1 ES8705883 A1 ES 8705883A1
- Authority
- ES
- Spain
- Prior art keywords
- group
- atom
- membered
- bonded via
- oxygen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyridine Compounds (AREA)
Abstract
METODO DE PREPARAR NUEVAS PIRIDAZINONAS. CONSISTE EN TRATAR UN ACIDO CARBOXILICO DE FORMULA (II) CON HIDRAZINA, EN METANOL, EN PRESENCIA DE ACIDO P-TOLUENSULFONICO Y ENTRE 20 Y 150JC, PARA OBTENER UN COMPUESTO DE FORMULA (I) Y SUS SALES FISIOLOIGICAMENTE COMPATIBLES CON ACIDOS, SIENDO: R1, ANILLO ALQUILENIMINO DE 5 A 7 MIEMBROS, SATURADO UNIDO A TRAVES DE NITROGENO, ANILLO IMINO Y OTROS; R2, H O UN GRUPO ALQUILO DE C 1 A 3; Y X, UN GRUPO IMINO EVENTUALMENTE SUSTITUIDO CON UN GRUPO ALQUILO O S. SE UTILIZAN COMO CARDIOTONICOS O ANTITROMBOTICOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19853511110 DE3511110A1 (de) | 1985-03-27 | 1985-03-27 | Neue pyridazinone, ihre herstellung und diese verbindungen enthaltende arzneimittel |
Publications (2)
Publication Number | Publication Date |
---|---|
ES557218A0 ES557218A0 (es) | 1987-05-16 |
ES8705883A1 true ES8705883A1 (es) | 1987-05-16 |
Family
ID=6266489
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES553463A Expired ES8705882A1 (es) | 1985-03-27 | 1986-03-26 | Procedimiento para preparar nuevas piridazinonas |
ES557218A Expired ES8705883A1 (es) | 1985-03-27 | 1986-11-21 | Procedimiento para preparar nuevas piridazinonas |
ES557219A Expired ES8705884A1 (es) | 1985-03-27 | 1986-11-21 | Procedimiento para preparar nuevas piridazinonas |
ES557220A Expired ES8705885A1 (es) | 1985-03-27 | 1986-11-21 | Procedimiento para preparar nuevas piridazinonas |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES553463A Expired ES8705882A1 (es) | 1985-03-27 | 1986-03-26 | Procedimiento para preparar nuevas piridazinonas |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES557219A Expired ES8705884A1 (es) | 1985-03-27 | 1986-11-21 | Procedimiento para preparar nuevas piridazinonas |
ES557220A Expired ES8705885A1 (es) | 1985-03-27 | 1986-11-21 | Procedimiento para preparar nuevas piridazinonas |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0196005B1 (es) |
JP (1) | JPS61227582A (es) |
KR (1) | KR860007253A (es) |
AT (1) | ATE48841T1 (es) |
AU (1) | AU5530386A (es) |
CA (1) | CA1257588A (es) |
DD (1) | DD248362A5 (es) |
DE (2) | DE3511110A1 (es) |
DK (1) | DK131886A (es) |
ES (4) | ES8705882A1 (es) |
FI (1) | FI861288A (es) |
GR (1) | GR860801B (es) |
HU (1) | HUT42085A (es) |
IL (1) | IL78251A0 (es) |
NO (1) | NO861266L (es) |
NZ (1) | NZ215616A (es) |
PT (1) | PT82272B (es) |
ZA (1) | ZA862248B (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3505609A1 (de) * | 1985-02-19 | 1986-08-21 | Merck Patent Gmbh, 6100 Darmstadt | Benzimidazolyl-pyridazinone |
US4725686A (en) * | 1985-11-22 | 1988-02-16 | William H. Rorer, Inc. | Benzodiazinone-pyridazinone and hydroxy-pyrazolyl compounds, cardiotonic compositions including the same, and their uses |
DE3611343A1 (de) * | 1986-04-04 | 1987-10-08 | Boehringer Mannheim Gmbh | Heterocyclisch substituierte benzimidazole, verfahren zu ihrer herstellung, arzneimittel sowie zwischenprodukte |
DE3734083A1 (de) * | 1987-10-08 | 1989-04-20 | Heumann Pharma Gmbh & Co | Benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
DE3735207A1 (de) * | 1987-10-17 | 1989-04-27 | Basf Ag | Mittel auf der basis von phenylpyridazinon-derivaten zur wachstumsfoerderung und fettreduktion bei tieren |
ES2080064T3 (es) * | 1988-07-11 | 1996-02-01 | Akzo Nobel Nv | Derivados de piridazinona. |
FR2643903A1 (fr) * | 1989-03-03 | 1990-09-07 | Union Pharma Scient Appl | Nouveaux derives de benzimidazole, leurs procedes de preparation, intermediaires de synthese, compositions pharmaceutiques les contenant, utiles notamment pour le traitement des maladies cardiovasculaires, et des ulceres duodenaux |
DE4237656A1 (de) * | 1992-06-13 | 1993-12-16 | Merck Patent Gmbh | Benzimidazolderivate |
FR2806093B1 (fr) * | 2000-03-08 | 2002-05-03 | Inst Francais Du Petrole | Procede d'hydrogenation selective comprenant une separation partielle d'hydrogene par membrane en amont d'une colonne reactive |
ES2388681T3 (es) | 2006-03-28 | 2012-10-17 | High Point Pharmaceuticals, Llc | Benzotiazoles con actividad de los receptores de histamina H3 |
JP5794297B2 (ja) * | 2010-05-07 | 2015-10-14 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Gpr119アゴニストとしてのピリダジノン |
WO2012149540A1 (en) | 2011-04-28 | 2012-11-01 | The Broad Institute Inc | Inhibitors of histone deacetylase |
EP2877444B1 (en) | 2012-07-27 | 2020-09-02 | The Broad Institute, Inc. | Inhibitors of histone deacetylase |
WO2014100438A1 (en) | 2012-12-20 | 2014-06-26 | The Broad Institute, Inc. | Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors |
WO2018086703A1 (en) | 2016-11-11 | 2018-05-17 | Bayer Pharma Aktiengesellschaft | Dihydropyridazinones substituted with phenylureas |
US20200360531A1 (en) | 2018-01-31 | 2020-11-19 | Bayer Aktiengesellschaft | Antibody drug conjugates (adcs) with nampt inhibitors |
WO2021013693A1 (en) | 2019-07-23 | 2021-01-28 | Bayer Pharma Aktiengesellschaft | Antibody drug conjugates (adcs) with nampt inhibitors |
WO2023003468A1 (en) | 2021-07-23 | 2023-01-26 | Rijksuniversiteit Groningen | Novel inhibitors of histone deacetylase (hdac), and methods, compositions and uses related thereto. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES482789A0 (es) * | 1978-08-25 | 1980-12-01 | Thomae Gmbh Dr K | Procedimiento para la preparacion de nuevos bencimidazoles sustituidos en posicion 5 o 6 con un anillo de piridazinona |
DE3129447A1 (de) * | 1981-07-25 | 1983-02-10 | Dr. Karl Thomae Gmbh, 7950 Biberach | "neue benztriazole, ihre herstellung und ihre verwendung als arzneimittel" |
DE3505609A1 (de) * | 1985-02-19 | 1986-08-21 | Merck Patent Gmbh, 6100 Darmstadt | Benzimidazolyl-pyridazinone |
-
1985
- 1985-03-27 DE DE19853511110 patent/DE3511110A1/de not_active Withdrawn
-
1986
- 1986-03-18 EP EP86103687A patent/EP0196005B1/de not_active Expired
- 1986-03-18 DE DE8686103687T patent/DE3667664D1/de not_active Expired - Fee Related
- 1986-03-18 AT AT86103687T patent/ATE48841T1/de not_active IP Right Cessation
- 1986-03-21 DK DK131886A patent/DK131886A/da not_active Application Discontinuation
- 1986-03-25 DD DD86288285A patent/DD248362A5/de unknown
- 1986-03-25 IL IL78251A patent/IL78251A0/xx unknown
- 1986-03-25 CA CA000505012A patent/CA1257588A/en not_active Expired
- 1986-03-26 GR GR860801A patent/GR860801B/el unknown
- 1986-03-26 JP JP61068255A patent/JPS61227582A/ja active Pending
- 1986-03-26 NZ NZ215616A patent/NZ215616A/en unknown
- 1986-03-26 NO NO861266A patent/NO861266L/no unknown
- 1986-03-26 PT PT82272A patent/PT82272B/pt unknown
- 1986-03-26 ZA ZA862248A patent/ZA862248B/xx unknown
- 1986-03-26 KR KR1019860002262A patent/KR860007253A/ko not_active Application Discontinuation
- 1986-03-26 HU HU861275A patent/HUT42085A/hu unknown
- 1986-03-26 AU AU55303/86A patent/AU5530386A/en not_active Abandoned
- 1986-03-26 ES ES553463A patent/ES8705882A1/es not_active Expired
- 1986-03-26 FI FI861288A patent/FI861288A/fi not_active IP Right Cessation
- 1986-11-21 ES ES557218A patent/ES8705883A1/es not_active Expired
- 1986-11-21 ES ES557219A patent/ES8705884A1/es not_active Expired
- 1986-11-21 ES ES557220A patent/ES8705885A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
CA1257588A (en) | 1989-07-18 |
EP0196005A1 (de) | 1986-10-01 |
ES8705885A1 (es) | 1987-05-16 |
JPS61227582A (ja) | 1986-10-09 |
IL78251A0 (en) | 1986-07-31 |
DE3511110A1 (de) | 1986-10-02 |
ZA862248B (en) | 1987-11-25 |
ES8705884A1 (es) | 1987-05-16 |
DK131886D0 (da) | 1986-03-21 |
KR860007253A (ko) | 1986-10-10 |
FI861288A0 (fi) | 1986-03-26 |
NZ215616A (en) | 1990-01-29 |
ATE48841T1 (de) | 1990-01-15 |
AU5530386A (en) | 1986-10-02 |
ES557218A0 (es) | 1987-05-16 |
GR860801B (en) | 1986-07-21 |
ES553463A0 (es) | 1987-05-16 |
NO861266L (no) | 1986-09-29 |
ES557219A0 (es) | 1987-05-16 |
PT82272A (de) | 1986-04-01 |
ES8705882A1 (es) | 1987-05-16 |
DD248362A5 (de) | 1987-08-05 |
FI861288A (fi) | 1986-09-28 |
EP0196005B1 (de) | 1989-12-20 |
ES557220A0 (es) | 1987-05-16 |
DE3667664D1 (de) | 1990-01-25 |
PT82272B (de) | 1988-01-06 |
DK131886A (da) | 1986-09-28 |
HUT42085A (en) | 1987-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8705882A1 (es) | Procedimiento para preparar nuevas piridazinonas | |
AP1654A (en) | Chemokine receptor binding heterocyclic compounds. | |
NZ334710A (en) | Heterocycle derivatives which inhibit factor Xa attributed to strong anticoagulant and antithrombotic effect of compounds | |
ES482134A1 (es) | Un procedimiento para preparar derivados de 1-(3-mercapto- 2-metilpropanoil)-prolil-aminoacido. | |
KR870007180A (ko) | 티에노-1,4-디아제핀의 제조방법 | |
GEP19970842B (en) | Oxadiazole-alkyl-purine derivatives | |
IE832503L (en) | 1,2,3,4-tetrasubstituted naphthalenes | |
ATE34978T1 (de) | Imidazolinon-derivate als histamin-h2antagonisten. | |
GB1214408A (en) | 3,5-diamino-6-halo-pyrazinamide derivatives | |
IL113677A (en) | Diamines and aminoamides and their preparation for use as intermediates for the preparation of 4, 5-dihydro-1h-2,4-aryl fused diazepines and benzodiazocines | |
EP0434982A3 (en) | 5-(amino)-triazolylcarbothioamide derivatives, process for their preparation and medicines containing them, as well as use of the former | |
ES8608491A1 (es) | Procedimiento para la preparacion de derivados de pirazol | |
JO1814B1 (en) | Therapeutic agents |